SCHEMBL24919029

SCHEMBL24919029

CC(C)(C)c1ccc2c(c1)C(c1ccccc1)(c1ccccc1)c1cc(N(c3ccc(-c4ccccc4)cc3)c3cccc(-c4cccc5ccccc45)c3)ccc1-2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA1 P02708 1/20 0.34
▸ CHRNG P07510 1/20 0.34
▸ CHRNB1 P11230 1/20 0.34
▸ CHRNB2 P17787 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ CHRNB4 P30926 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ CHRNA3 P32297 1/20 0.34
▸ CHRNA4 P43681 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ CHRND Q07001 1/20 0.34
▸ MCL1 Q07820 1/20 0.34
▸ ACMSD Q8TDX5 1/20 0.34
▸ PPARG P37231 3/20 0.33
▸ PPARA Q07869 3/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ CA12 O43570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23225131 0.98 GPR84 (0.35) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL23238784 0.92 MCL1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL23237383 0.91 MCL1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL24817303 0.91 CA12 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL23238785 0.90 MCL1 (0.33) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL25822997 0.90 PPARG (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL24817301 0.90 CA12 (0.33) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL23237381 0.90 MCL1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL26884534 0.90 CA12 (0.35) MCL1ACMSDPPARGPPARAGPR84
SCHEMBL23237004 0.90 MCL1 (0.35) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 CHRNA1 2805/4885CHRNG 3714/4885CHRNB1 3423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback